|
The Florey Institute of Neuroscience and Mental Health, previously known as the Howard Florey Institute of Experimental Physiology and Medicine, is an Australian medical and research institute that undertakes clinical and applied research into treatments for brain and mind disorders and the cardiovascular system. The institute is based at the University of Melbourne and in 2007 employed 300 staff and students, including many scientists and postgraduate students from overseas. Areas being researched by scientists include Parkinson's disease, stroke, motor neurone disease, traumatic brain and spinal cord injury, addiction, epilepsy, multiple sclerosis, brain development in premature babies, Huntington's disease, depression, schizophrenia, brain function in health and disease, heart failure, and dementia. ==History== The origins of the institute are based on the 1947 work of the founder, Dr. Derek Denton, and the investigation of the team of scientists, Prof R D Wright,Prof J P Coghlan and Prof Marelyn Wintour-Coghlan into the control of salt and water balance in health and disease. The Institute was formally established in 1971 by the Victorian State Government and named after Howard Florey, the Australian Nobel prize winning scientist who isolated the active principle of penicillin and developed the first manufacturing process for the antibiotic. The Institute conducted research into physiological control of body fluid and electrolyte balance, especially the regulation of the adrenal salt-retaining hormone, aldosterone; micro measurement of hormones; hybridization histochemistry; instincts that control ingestion; and the Relaxin hormone. In 1997 the Board made the strategic decision to change the Institute’s focus to brain disorders. From 1997 to 2007, the neuroscientist Professor Frederick Mendelsohn AO, led the institute. The current Director is Professor Geoffrey A. Donnan, AO. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Florey Institute of Neuroscience and Mental Health」の詳細全文を読む スポンサード リンク
|